Importantly, the lncMX1–215 level increased after IFNα treatment, and lncMX1–215 negatively regulated the expression of two key immunosuppression molecules, PD-L1 and galectin-9, which reversed IFNα-induced immunosuppression in HNSCC. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.